Patrick Jamieson

VP, Strategy & Corporate Development at Motional


Patrick Jamieson is the VP of Strategy & Corporate Development at Motional. Patrick has previously served as a Board Observer for KRONO-SAFE, Affectiva, and otonomo. From April 2018 to December 2019, they were the Director of Strategic Investments at Aptiv. Prior to that, they held various positions at GSK from July 2014 to June 2016, including Director, Business Development & Licensing, and Associate Director, Business Development & Licensing. From June 2013 to July 2014, they were Manager, Business Development & Licensing at Novartis Consumer Health. Patrick began their career as a Financial Planning Intern at Ameriprise Financial Services, Inc. in September 2008 and then went on to Thermo Fisher Scientific where they served as Segment Finance Manager from August 2011 to June 2013 and Finance Associate from June 2009 to August 2011.

Patrick Jamieson holds a Bachelor of Science in Economics-Finance from Bentley University, as well as a Negotiation for Executives certificate from MIT Sloan Executive Education. Patrick also has a Bachelor of Science in Economics-Finance from Copenhagen Business School.

Patrick Jamieson works with Peter Simshauser - General Counsel, David Helton - VP, Program & Systems, and Gretchen Effgen - VP, Go to Market and Marketing. Patrick Jamieson reports to Karl Iagnemma, President & CEO.


View in org chart


  • VP, Strategy & Corporate Development

    Current role

View in org chart

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.